NEW YORK (GenomeWeb News) – Nanotechnology firm NanoInk today said that it has launched a new division called NanoBioDiscovery that will focus on supplying technologies for biomarker research and drug discovery.

 

The Skokie, Ill.-based firm said that the new division will use its Dip Pen Nanolithography nanofabrication techniques and detection systems to produce assays for protein discovery and identification. It believes its technology can provide researchers with enhanced reaction kinetics and assay cost savings.